Table 4.
Antibiotic sensitivity of isolates in this study
| Antibiotic | Class | Sensitive | Intermediate | Resistant |
|---|---|---|---|---|
| Ceftriaxonea | Cephems | 100 % (n = 13) | 0 % (n = 0) | 0 % (n = 0) |
| Ciprofloxacin | Fluoroquinolones | 100 % (n = 13) | 0 % (n = 0) | 0 % (n = 0) |
| Erthromycin | Macrolides | 100 % (n = 13) | 0 % (n = 0) | 0 % (n = 0) |
| Oxacillin | Penicillins | 100 % (n = 13) | 0 % (n = 0) | 0 % (n = 0) |
| Penicillin | Penicillins | 84.6 % (n = 11) | 7.7 % (n = 1) | 7.7 % (n = 1) |
| Tetracycline | Tetracyclines | 100 % (n = 13) | 0 % (n = 0) | 0 % (n = 0) |
| Vancomycin | Glycopeptides | 100 % (n = 13) | 0 % (n = 0) | 0 % (n = 0) |
aBreakpoints based on FDA guidelines [57]
Brekpoints are based on CLSI guidelines, with the exception of ceftriaxone, which uses the FDA brekpoints